Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Clinical trial NCT03043820 · COMPLETED

Trial details

NCT number: NCT03043820
Sponsor: Iris Sommer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Psychosis NOS

Start date: 2016-08-01
Primary completion: 2021-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.